Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 30, 2023 12:55 ET | Source: Azure Biotech

Azure Biotech Announces Educational Initiative to Create Awareness of Unmet Women’s Menopausal Medical Issue

RIVER VALE, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Azure Biotech, Inc., a privately held women’s health company that is developing novel formulations of lasofoxifene for vulvovaginal atrophy (VVA),...
May 29, 2023 12:30 ET | Source: Transparency Market Research

Dyspareunia Treatment Market Poised for 4.1% CAGR Surge, Touches USD 1.02 Billion by 2031 | Transparency Market Research

Wilmington, Delaware, United States, May 29, 2023 (GLOBE NEWSWIRE) -- The dyspareunia treatment market generated US$ 689 million in 2022. Globally, the market is expected to reach US$ 1.02 billion...
October 23, 2019 07:30 ET | Source: Harrow Health, Inc.

Solas BioVentures Co-Founder David Adair, M.D. Joins Mayfield Pharmaceuticals Board of Directors

BOSTON, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Mayfield Pharmaceuticals, the women’s health-focused subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced David Adair, M.D. will join the...
October 08, 2019 07:35 ET | Source: Harrow Health, Inc.

Mayfield Pharmaceuticals to Present at the SVB Leerink New Treatments Focused on Women’s Health Conference on October 10, 2019

BOSTON, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Mayfield Pharmaceuticals, the women’s health-focused subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced its Chief Executive Officer, Melissa...
July 31, 2019 07:30 ET | Source: Harrow Health, Inc.

Harrow Health Announces Launch of Mayfield Pharmaceuticals

NASHVILLE, Tenn., July 31, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), today announced it has filed a Form 8-K with the Securities and Exchange Commission containing a corporate...
February 07, 2019 07:00 ET | Source: Harrow Health, Inc.

Harrow Health Subsidiary, Mayfield Pharmaceuticals, Inc., Acquires Patented Dyspareunia Drug Candidate and Other Intellectual Property

SAN DIEGO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), today announced that its subsidiary, Mayfield Pharmaceuticals, Inc., has acquired drug formulation assets and...